SYZJ-001

N/A

Report date: 2024/11/14 16:49:51

Base Information

Drug NameSYZJ-001

Drug Alias NameSYZJ001

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAngiotensin-converting enzyme 2 inhibitorsCoronavirus spike glycoprotein modulators

TargetsAngiotensin-converting enzyme 2Coronavirus spike glycoprotein

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesShanghai Zj Bio-Tech Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShanghai Zj Bio-Tech Co Ltd

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A